Welcome to From Insults To Respect. Today’s topic–money.
The way we handle money can influence how much respect we have for ourselves and others have for us. A classic illustration comes from Charles Dickens’s A Christmas Carol where we find the unforgettable Ebenezer Scrooge transformed by ghostly experiences from a disrespected miser to a lovable, generous employer. As we delve into our topic, we will draw upon a couple of episodes of Bob Dylan’s Theme Time Radio Hourshow, both of which happen to be on the theme of money.
Money, Part One
As Bob introduces the first of his two episodes on money, he tells us, with reggae music in the background,
…we’re gonna take our cue from a sign Harry S. Truman kept on his desk: The Buck Stops Here. And not just the buck, the yen, the shekel, the nickel and dime, and if you still subscribe to the barter system, maybe a bushel of corn. So break open your piggy banks and cash in your bonds. This week’s episode of Theme Time Radio Hour is most definitely cash and carry.
Then, Bob plays us a recording of a man who sounds like someone delivering a US service announcement;
Wherever we go we see money being used as a medium of exchange. Money is a convenient method of exchanging many kinds of goods among many persons. Money is also a standard of value. The value of goods is stated in terms of money.
The first song Bob plays for us is the bluesy “That’s What They Want.” Performed by Jerry McCain and His Upstarts, it tells about a guy grieving about the women he knows who are just interested in finding men who have a lot of money, and a Cadillac too.
They don’t want no man, Who don’t got no cash. They’ll tell you quite quick, They don’t mess with trash.
That’s what they want, Oh yeah, money honey.
They don’t want no lovin’ No 24 hours a day, They just want to know When you get your pay.
That’s what they want, Oh yeah, money honey.
There is some fine harmonica playing on that one. As I interpret the song, the singer appears to be upset with women who view a guy as trash because he doesn’t have money. He’s looking for a gal who would be satisfied with a loving guy who will always be there for her. It captures the tension between wanting a relationship in which all of your material desires are achieved, versus the willingness to give up some, or all of that for someone whom you truly love because of his or her more intrinsic values. Reflective of this tension, over the years, I observed on occasion a guy or gal pointing to someone’s spouse while saying with disdain, “She married for money,” or “He married for money.”
A little later in the show, Bob tells us that some people will do anything for money. And then, setting up the next song, he says:
I almost think we play too much Van Morrison, but then I play one of his records and I say, “No we don’t.” Here’s one that Van recorded back in 1970, from his album, His Band and the Street Choir–“Blue Money.”
Blue money, according to the Urban Dictionary, refers to 100 dollar bills, which got its name from a blue line that goes up and down the bill. But in some circles, it means money from making porn movies. Thus, according to this interpretation, the song is about the singer’s girlfriend making porn movies, which involves engaging in sexual activities for money.
For many, people who make porn movies are looked down upon. There are better ways to make money, they say.
Although I personally believe there are indeed better ways to make money, I have some mixed feelings about completely losing respect for those who do earn money by engaging in sex. It comes from a couple of unique personal experiences.
When I was an undergraduate at Brooklyn College, I drove a taxi in Manhattan to cover my expenses. From time to time, as I was driving past the Port Authority, where buses and trains would bring loads of out-of-towners to the city, a few women dressed in very scanty, sexy outfits would jump in my taxi and tell me to drive around the block. As they peeked out the window, I could tell they had spotted some police officers, and they had me keep circling the block until the men in blue were gone.
Prior to this, I did think of those involved in this type of business in a pretty negative light, but this experience, meeting them in this strange way, well, I got to see a more human side of them as they talked among themselves in the taxi. I still feel that for myself there are far better ways to earn money, but this experience softened my unkind attitude toward those in the “Blue Money” trade.
Later, while a graduate student at the University of Minnesota, I worked at a Juvenile Correctional Facility, where I honed my counseling skills. Several of the female teenagers were in the facility because they had been engaged in prostitution. Here, I got to know what led these young ladies into this path to earn money. All came from extremely stressful financial situations. All were first lured into becoming hooked on drugs, which initially relieved their financially strapped stress. The leaders of the industry provided, at first, the drugs for free, along with other enticing gifts. In time, desperate to feed their addictions, these teenagers found turning tricks were the only way they knew how to survive. Somehow, during the counseling sessions, their humanity came to light, and a more kind and understanding attitude was fostered.
As Bob’s show continues, Bob plays for us, Nic Jones’s “Farewell to the Gold.” It provides a touching story of a man who, with a friend, spends his life hoping to strike it rich by prospecting for gold. In the end, his dream never comes true, and a flood leads to his friend drowning. The story is a metaphor for the real possibility that seeking gold doesn’t always work out well, and it’s important to be aware of this if we are to wisely choose our life’s pursuits.
In another song, this one called “Your Cash Ain’t Nothin’ but Trash,” by the Clovers, we hear about a woman who, in contrast to the women earning money in the Blue Money industry, this woman refuses to lower herself to a guy flashing his roll of dollars:
I was walking down the main track One night I met a fine chick She was built just right
She stopped when I flashed my roll I told her she could have all of my dough
She turned around and with a frown She said this ain’t no circus And I don’t need a clown
Your cash ain’t nothin’ but trash Your cash ain’t nothin’ but trash Your cash ain’t nothin’ but trash And there ain’t no need in your hangin’ around
As this episode winds down, Bob plays us, “You Can’t Take It With You” by Jessie Price. If you like piano, clarinet, and trumpet solos, this number is sure to put a smile on your face. And then, Bob concludes with the following words:
That was, “You Can’t Take It with You,” and one reason you can’t take it with you is that it usually leaves before you do. You know, I’m looking at my bag of records, and I brought too many again–bad planning. There are just too many songs about money to fit into a single hour, and there is no reason to cut fiscal corners. Hell, we did two shows about birds last year so we could do two about money. So, next week, we’ll dig back into our pockets, and continue to look at the filthy lucre. Join us again in seven days as we present part two of the Almighty dollar. Two shows about money, it makes good cents. See you next week.
Part Two
Bob begins part 2 by welcoming us back to the show. And then he says:
If you were listening last week, and if you weren’t, what the hell is wrong with you, but if you were listening last week, you know we started our look at cold hard cash. We had too many songs, so here we are back again.
Soon, Bob plays for us “I’ve Got Money,” sung by an incredibly energetic James Brown. It’s all about a guy who has money but still needs love. Some of the lyrics go like this:
I’ve got money And now I need love When I get my lovin’ I’ll be the happy one
The theme, it seems to me, is money without love, is simply not enough for a full life.
At one point, Bob answers his phone:
Bob: Hi caller, you’re on the air.
Caller: Hi Bob.
Bob: Where are you from?
Caller: Carbondale, Illinois.
Bob: What’s your name?
Caller: Carol.
Bob: Well, Carol, what can I do for ya?
Caller: I heard last week’s money show and I really enjoyed it.
Bob: Hey, thanks a lot. We worked hard on it.
Caller: It shows. I heard you were doing another one this week, and I was wondering if I could make a request?
Bob: What do you want to hear?
Caller: The Beatles’ song, “Money Can Buy Me Love.”
Bob: Carol, I think it’s, “Money Can’t Buy Me Love.”
Caller: No, No, it’s can buy me love. I have the record, so I know.
Bob: [insisting] Carol, It’s “Money Can’t Buy Me Love.”
Caller: I know you are Mr. Sixties, but I have the record. It’s can buy me love.
Bob: All right, Carol. We’ll look for it. Keep listening.
Caller: Thanks Bob.
Bob then hangs up, let’s out a long sigh, and says, “You can’t help some people. Carol, if you’re still listening, money can not buy you happiness, but it can buy you more places to look. Still looking for that song, but in the meantime, let’s listen to one by the Drifters.”
After some background remarks about the Drifters, Bob plays their song, “Money, Honey.” With the smooth voice of Clyde McPhatter, and some fine sax solos, the lyrics go,
You know, the landlord rang my front door bell I let it ring for a long, long spell I went to the window and peeked through the blind, And asked him to tell me what was on his mind
He said, “Money, honey! Yes, money, honey! Mhm, money, honey, If you want to stay with me.
I was cleaned and skinned and so hard-pressed I called the woman that I love the best I finally reached my baby ’bout a half past three She said, “I’d like to know what you want with me”
I said, “Money, honey! Money, honey! Money, honey, If you want to get along with me”
She screamed and said, “What’s wrong with you? From this day on, our romance is through.” I said, “Tell me, baby, face to face How could another man take my place?”
She said, “Money, honey! Money, honey! Money, honey, If you want to get along with me.
Now I learned my lesson, The wind may blow, Before I pay I will love them so.
No doubt that in some situations, without money it is hard to get along. The solution, of course, is to find some respected ways to earn some, or find situations where money is not so essential.
As the show draws to an end, Bob tells us:
We spent so much time talking about money, I want to leave you with someone who had an opposing opinion. He’s a smart guy about relativity, and he’s smart about this. We’re talking about Einstein, and he said, “I’m absolutely convinced that no wealth in the world can keep humanity from moving forward. Even in the hands of the most devoted worker the examples of great pure individuals is the only thing that can move us to noble thoughts and deeds. Money only appeals to selfishness and irresistibly invites abuse. Can anyone imagine Moses, Jesus, or Gandhi armed with the bags of money of Carnegie.” We’ll see you next week with all new themes, dreams, and schemes.
Well, that’s my post for today. I hope it provides some useful perspective on the relationship between the nature of respect and how one goes about fulfilling a desire for money.
———————————
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional intelligence. To begin at the very first post you can click HERE.
Welcome to From Insults To Respect. As several of my earlier blog posts have indicated, many professionals, mental health service users, involuntary patients, and the general public have little, to no respect, for the American Psychiatric Association’s most recent version of its Diagnostic and Statistical Manualof Mental Disorders (DSM-5).
Just before the DSM-5 was published, early drafts were made available, and in 2011 the British Psychological Society (BPS) and the American Psychological Association’s Society for Humanistic Psychology expressed concern that:
…clients and the general public are negatively affected by the continued and continuous medicalisation of their natural and normal responses to their experiences; responses which undoubtedly have distressing consequences which demand helping responses, but which do not reflect illnesses so much as normal individual variation…
Additionally, many researchers have pointed out that psychiatric diagnoses are plagued by problems of reliability, validity, and prognostic value.
These concerns, among others, appeared in an Open Letter to the DSM-5 developers that was endorsed by over 15,000 mental health professionals and other individuals, as well as by over 50 professional organizations, including 15 additional divisions of the American Psychological Association. These concerns were largely ignored by the DSM-5 developers.
Since then, we have seen the development of a few proposals for alternative frameworks. Most of them continue to pathologize those seeking mental health services.
In contrast, there is now my own proposed alternative, the Classification and Statistical Manual of Mental Health Concerns (CSM) which I presented at the American Psychological Association’s Annual Convention, and published in a peer reviewed psychology journal (see HERE). The CSM approach recognizes mental health professionals require some classification system for providing a common language for them to communicate about those utilizing their services. These terms must, for practical purposes, be short phrases that are convenient for placing them into titles and search engines, and for efficient/streamlined communication in the often hectic environments of many hospitals and clinics.
However, unlike the CSM, other frameworks being proposed use the term “diagnosis,” which implies that the mental health professional, once providing the diagnosis, now knows the cause of the concerns being expressed by the person seeking services, which is simply not true. Instead, they may have some tentative theory for the cause or be completely puzzled. Nevertheless, to access services, the misleading diagnosis is provided. Moreover, the “diagnostic” terms used identify and locate problems within individuals and labels the individual as having a mental disorder, which is often stigmatizing.
In contrast, the CSM does not seek to label anyone. Instead, it classifies the expressed concerns of those seeking mental health services, using the typical non-jargon phrases employed by them. These phrases would become the short phrases that would be used by mental health professionals for titles and search engines, and for efficient/streamlined communication.
Beyond creating this practical classification system, the CSM then relies on a psychological formulation approach that opens the door to finding causes for these types of concerns in the circumstances of the service seeker’s lives. Locating problems within only individuals, as the DSM-5 does, misses the relational context and undeniable social and structural influences on many of these concerns.
I developed the CSM approach while working with the Task Force on Diagnostic Alternatives of the American Psychological Association’s Division 32 (Society of Humanistic Psychology). That group has not officially supported, as of yet, any single alternative. Instead, it has wisely decided that its next step is to send out a new open letter hoping to garner support for starting a process that will involve all of the mental health stakeholders including former and current mental health service users, individuals who experienced involuntary treatment, their family members, and mental health professionals.
Why bother to create a new open letter to those who are in positions that can really make meaningful changes since the last one was largely ignored? It is because of a deep understanding of how meaningful positive changes do occur. Advocates for change are, at first, largely ignored. Then, through continued advocacy, some meaningful discussions do get underway. And finally, positive changes occur. The process by which women obtained the right to vote is one notable example of this.
So, this letter was created with the flame of hope still flickering within the hearts of many of us.
The letter is addressed to:
Co-Chairs of the World Health Organization Joint Task Force (JTF) on the ICD-11 for Mortality and Morbidity Statistics,
Stefanie Weber, MD
Head, Medical Vocabularies
German Institute for Medical Documentation and Information (DIMDI)
Waisenhausgasse 36-38A
50676 Cologne, Germany
James Harrison
Director, Research Centre for Injury Studies
Flinders University, Adelaide Australia
GPO Box 2100 Adelaide SA 5001 Australia
Chair, DSM Steering Committee:
Paul S. Appelbaum, MD
Elizabeth K Dollard Professor of Psychiatry, Medicine & Law
New York State Psychiatric Institute
1051 Riverside Drive, #122
New York, NY 10032
Coordinator, RDoC:
Bruce N. Cuthbert, PhD
National Institute of Mental Health
NSC BG RM 6200
6001 Executive Boulevard
Rockville MD 20852
I was one of the consultants that helped to craft the letter. Among the main points that it seeks to make are:
In practice, diagnoses are not conferred in a contextual vacuum. The criteria are not culture or value-free but instead reflect current normative social expectations. At the same time, psychiatric diagnoses have substantial impact on the social and occupational lives of those to whom they are applied. And reductionist biomedical diagnoses obscure the social determinants of our distress. This is important: as the United Nations Special Rapporteur concluded in 2017, we are under an international obligation to ensure that mental healthcare adequately addresses social contexts and relationships.
The letter concludes:
As a next step to address these concerns, we request an online, telephone or in-person meeting to discuss these issues in more depth. We look forward to your response.
Readers of this blog are invited to read this letter HERE.
Welcome to From Insults to Respect. Today we once again take up the controversial topic of the usefulness of the group of drugs referred to by psychiatrists and the pharmaceutical industry as “antipsychotics.” In most of the articles that I have read that have been written by psychiatrists, “antipsychotic” drugs are the first line of treatment for schizophrenia. And yet, a growing number of mental health advocates have been fiercely critical of this. As someone who has given considerable thought to helping people resolve challenging conflicts, I set myself on trying to find out what is going on here. After a review of the scientific research and participating in several debates, I then wrote three blog posts that reported to my readers what I have found.
In the first post, I conclude that the weight of the evidence indicates these drugs are causing far more harm than good. In the second post, I explain how people come to have the illusion that these drugs are helpful. Upon publishing the first two posts, several defenders of the use of these drugs claimed these drugs are worth using because they reduce the risk of early mortality. I, therefore, published a third post that reviews the mortality research studies. As it turns out, some rather weak evidence does exist that appears to support a positive correlation between “antipsychotic” use by those labelled as having schizophrenia and reduced early mortality. However, those studies have significant flaws and more convincing evidence exists suggesting these drugs actually increase the risk of early mortality.
A recent article published in the prestigious medical journal The Lancet, succinctly summarizes much of this research:
[The evidence] “shows that many patients choose to refuse or discontinue their pharmacological treatment…. Patients with psychosis are often ambivalent about taking drugs, 6 and evidence suggests that the effectiveness of such drugs has been overestimated, whereas the severity of their adverse effects have been underestimated.7 A systematic review concluded that the improvements claimed for antipsychotics are of questionable clinical relevance, 8 and a multiple-treatments meta-analysis 9 showed that although differences in efficacy between antipsychotics and placebo were noted, they were smaller than those for most of the analysed adverse effects.10 Research suggests that adverse effects include structural abnormalities in brain volume,11 increased risk of sudden cardiac death,12 and substantial weight gain induced by antipsychotics,13 which is associated with cardiovascular and metabolic risks.”
In addition to the adverse effects and lack of clinically meaningful positive effects, there is an enormous cost to using these drugs, costs that are siphoning off resources that could be better used for more healthy alternatives. The cost for the drug approach is not just confined to the cost of the “antipsychotic” drugs which has been estimated to be in the range of several billions of dollars. Doctors often prescribe a whole cocktail of drugs for these patients, dramatically adding to the cost of the drug approach, while evidence indicates the combination of “antipsychotics” with these other drugs often leads to additional adverse effects. The cost of the doctors’ time for prescribing and monitoring the treatment must be added, as well, as the cost of the revolving door of placement in a hospital, releasing from the hospital, and readmitting to the hospital, which has been the frequent pattern with this drugging approach. Finally, we must add the cost of treating patients for all of the adverse effects of these drugs.
Given all of these problems, what alternatives to “antipsychotic” drug management are out there?
The Alternatives
There are several very promising alternatives, but in most regions they are not yet available. Articles like mine are designed to expand the general population’s knowledge of just how ineffective, harmful, and financially wasteful the drug treatments are, and that there are safer alternatives. This increased awareness campaign has been a major reason for the slow rising tide of advocates demanding that these more healthy alternatives become readily accessible in every community.
With this background, let’s take a look at these more healthy, humane alternatives.
Cognitive Therapy
A study funded by England’s National Institute for Health Research was published in 2014, that carried out a single-blind randomized controlled trial. Participants aged 16–65 years who were labelled as having schizophrenia spectrum disorders, and who had chosen not to take antipsychotic drugs, were randomly assigned to either receive cognitive therapy plus treatment as usual, or just treatment as usual. Outcome assessors were masked to group allocation.
The authors summarized their results as follows:
“Cognitive therapy significantly reduced psychiatric symptoms and seems to be a safe and acceptable alternative for people with schizophrenia spectrum disorders who have chosen not to take antipsychotic drugs. Evidence-based treatments should be available to these individuals. A larger, definitive trial is needed.
The central features of this treatment for this group of patients involve normalization and evaluation of the appraisals that people make, helping them to test such appraisals with use of behavioral experiments, and helping them to identify and modify unhelpful cognitive and behavioral responses. Additionally, it aimed to provide warm, empathic, and non-judgmental face-to-face contact, supportive listening, signposting to appropriate local services for unmet needs, and crisis management when needed.
Treatment as usual was variable across both sites. In practice, participants within these services received regular care-coordination and psychosocial interventions, including the offer of family interventions.
On average, neither group deteriorated over time, in a population that has been assumed to deteriorate without total adherence to drugs; in fact, some participants receiving treatment as usual who were not taking drugs achieved good clinical outcomes, and more did with the addition of cognitive therapy. The study also showed that cognitive therapy is an acceptable intervention for a population who are usually considered to be very challenging to engage by mental health services, with low rates of drop out and withdrawal. The effect size on psychiatric symptoms in the study is similar to the median effect size reported for overall symptoms in a large meta-analysis of 15 antipsychotic drugs versus placebo.
Humanistic Approaches
A recent issue of the Journal Of Humanistic Psychology (JHP) is devoted to the humanistic perspective on understanding and responding to extreme states. There you will find several non-antipsychotic approaches for addressing psychological concerns that are labelled as schizophrenia by psychiatrists.
In one of the articles, Yana Jacobs, who once worked as a staff member at Soteria House, tells us about its approach. Funded by the National Institute of Mental Health, Soteria House provided a place to live for people who fit the criteria for schizophrenia and having their first episode. These patients were given the choice of staying at the hospital where they had first been labelled, or coming to Soteria, where “antipsychotics” usually would not be used. As Yana describes the program,
“All six residents were given their own private room and had the freedom to do what they felt like. This might include staying in their bedroom, sleeping all day, or hanging out in a living room and listening to music or chatting with whomever was around. Relationships developed naturally, and we all got to know one another to various degrees, no different than how we develop friendships. This was not a therapist-patient relationship but rather a sort of social relationship. As a staff member I had some responsibilities—going to the market and preparing dinner. Everyone was on their own for breakfast and lunch and could help themselves to whatever they might like. Grocery shopping was often an outing to the market. Usually, one or two residents would accompany me to the store. When we returned, I would ask for help prepping the meal. It was quite informal. The house was often a bit of a mess, but then, we’d all get together and decide it was time for a quick house cleaning and again, whoever wanted to join would do so.”
For those who have come to believe that without the use of “antipsychotics” all hell would break out and the world would pretty much come to an end, consider Yana’s experience:
“I never felt like I was ‘working,’ and honestly, I loved being at Soteria so much that it wasn’t till the end of my employment that I even took note of how much I was being paid. There’s something about being with people when they are going through a difficult time that is such a privilege and truly an honor to be part of this intimate journey.”
Yana explains that there were times when someone was going through deep pain, tears, screaming, throwing things, and sleeplessness, “but always something would emerge and calm would eventually arrive, you really had to have faith in the process.”
Since the original Soteria House opened and funding ran out, several other programs based on a similar model took its place. Berne, Switzerland has had a Soteria House since 1984, and Soteria houses in Vermont and Israel recently opened.
Soteria House programs are designed to help people through an original episode of an extreme experience typically labeled as schizophrenia. The stay at one of these houses lasts for just a few months.
Another approach well described in the JHP special issue is written by Charles Knapp. The Windhorse therapeutic perspective has a Tibetan Buddhist orientation that offers meditation, and spiritual teachings, along with a supportive, empathetic staff. Unlike the Soteria House approach, which aims to support people through a recovery process over a few months, the Windhorse approach recognizes that individual recovery periods are highly variable, and it is not uncommon for people to stay in their programs for eighteen months and even longer.
There are several other approaches described in the JHP special issue, all worth while to think about. All have had their share of success in helping to provide support for people experiencing extreme states.
That said, I would be negligent if I didn’t say that no approach currently available manages to avoid having some disappointing results. This is true for the standard medical model which urges all people labelled as having schizophrenia to immediately take “antipsychotics,” and it is also true for all of the alternative approaches discussed above. However, those alternatives lead to far fewer people eventually choosing to take “antipsychotics,” thus decreasing the chances of people experiencing the various adverse effects associated with consuming “antipsychotics.”
Beyond the decreased risk of “antipsychotic” adverse effects, available research can not say for sure that these alternatives lead to additional improved life outcomes. Nevertheless, results have been very encouraging, and it is high time that these alternatives become far more accessible while high quality ongoing research better assesses what works well, and what needs to be modified.
———————————
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional intelligence. To begin at the very first post you can click HERE.
Welcome to From Insults To Respect. Today’s post takes a close look at an exchange that Senator Martha McSally of Arizona had with CNN Reporter Manu Raju while he attempted to ask her a question in a Capitol Hill hallway.
The exchange went like this:
RAJU: Senator McSally, should the Senate consider new evidence as part of the impeachment trial?
McSALLY: You’re a liberal hack. I’m not talking to you.
RAJU: You’re not going to comment, Senator?
McSALLY: You’re a liberal hack, buddy.
You can view the exchange on YouTube HERE. There you can readily see that Mr. Raju asked Senator McSally the question in a professional manner, and she clearly responded with disgust in her voice.
McSally on Left and Sinema on Right
A little background on the Senator might be helpful. She was not elected to her position. She lost to Kyrsten Sinema and was then appointed to fill the seat vacated by Senator Jon Kyl. Currently she is in a very competitive race against Mark Kelly, hoping to be elected as Senator this coming November.
There’s been talk that McSally staged the episode to excite the Republican base. And indeed, Republicans are already using it to raise money for her reelection campaign, in which McSally is very vulnerable.”
Supporting this notion that the incident was staged is that McSally quickly posted the video. Fox News host Sean Hannity instantly began to praise her conduct, and she got additional publicity by appearing on Laura Ingraham’s Fox News show. Meanwhile, President Trump’s 2020 campaign tweeted out “THREE CHEERS” for the senator while directing followers to donate to her campaign. To me, this appears to be a bit too choreographed to have come out of an unplanned emotional outburst.
That said, I hasten to say, I did not choose this incident in order to attack a Republican candidate. Instead, I chose it because just as I was about to write today’s post the McSally incident happened to go viral. The incident, therefore, is particularly fresh in the minds of readers and of high interest, so that it serves as a useful jumping off point to address issues relevant to this blog. Before going on, in an effort to be fair, I point out that I personally have seen both Democrats and Republicans throw insults at news outlets that tend to be biased toward their opposing political party.
Why Did The Incident Go Viral?
Although it is not unusual for both Democrats and Republicans to insult news outlets when it publishes a specific negative story about their representatives, this McSally incident is nevertheless unusual for the following reason. We don’t typically see a senator, upon being asked a reasonable question by a reporter, responding disrespectfully, quickly post it on line, and then have the president cheer the insulter.
Senator McNally received a great deal of free press coverage, so should this become the new norm? Is this really how Americans want to see their elected officials respond to reporters? And do we really want our kids learning to insult everyone they disagree with by observing our national leaders acting this way? I suggest that the anxiety provoked by these questions are at the heart of why the McSally incident went viral.
A Paradox
On the one hand, there is a considerable amount of evidence that people who are very insulting tend to be less liked and respected. On the other hand, many politicians can be very insulting toward people with whom they disagree, and despite this, they win elections and many people idolize them.
Explaining the Paradox
First of all, the negative effects of being insulting is strongest in interpersonal relationships. As I define these terms, your interpersonal relationships are your interactions with people with whom you have direct, face to face interactions on an ongoing basis.
The relationship that politicians have with voters is best viewed as an intergroup relationship. The intergroup relationship I’m discussing today regarding McSally involves the group of people who might potentially vote for her, the groups of people who have a vested interest in getting her elected, and the groups of people who are working to get someone else elected. Although insulting people is relevant to intergroup relationships, other issues often become more important.
In an interpersonal relationship, if you attempt to insult the person with whom you are personally interacting, that person might insult you back and the interaction can escalate into violence. In fact, the most common reason people turn to violence is because they felt someone treated them disrespectfully.
When we see politicians seeking to insult someone, they are modeling for others this type of violence producing behavior. But what makes this type of behavior very different for politicians is that they almost always have a group of supporters standing by them and a team of armed security personnel well trained to intervene if an insulted party makes any moves at all that can be viewed as violent. Under this set of circumstances, it is far safer to play the part of a tough person who doesn’t take any crap. Meanwhile, as politicians model this behavior for people without the protections afforded to politicians, it can potentially increase levels of violence for non-politicians.
Here’s another difference between what typically happens during your interpersonal relationships and the intergroup interactions that involve politicians. When someone directly seeks to insult you, unless you are well trained in handling this in a peaceful manner, you are likely to take the insult personally. The emotions that arise in this situation are more likely to be stronger than typically experienced when groups of people see on TV or in a large arena a politician throwing insults at someone they don’t personally know.
Politicians, moreover, are not seeking to develop a sound interpersonal relationship with you. They are, instead, seeking your vote. They know very well that not everyone is going to vote for them. If they anger the voters who aren’t likely to vote for them anyway, and end up getting 51 percent of the vote, this, to them, is success.
Now, when it comes to interpersonal relationships, if you act in a manner that leads to even a minority not liking you, this can lead to far more direct problems for you than if a minority of people don’t vote for some politician. If those who personally know you don’t like you, they can begin to say things behind your back to people who actually personally interact with you. Some of what gets said can be untrue and very unfair, but you may never hear about this. This behind your back treatment may result in people that you like no longer inviting you to parties. When you used to be invited to go bowling, now someone else is getting invited. In a work setting, you may be passed up for promotion. These types of consequences can have direct effects on your personal life. For politicians, the personal effects that may occur if they anger a minority of people who would have been unlikely to vote for them, would be far less important to them than getting elected.
Also, note that when people decide on who to vote for, they consider many issues, not just whether or not the candidate insults anyone. When politicians insult someone, many voters are apt to say to themselves, they aren’t doing anything much different than all the other politicians. These voters then choose a candidate based on other issues. If some voters recognize that a particular politician insults others more than other candidates, they may feel that his or her stand on immigration is a far more important issue.
Others will actually like the insulting because the insults are aimed not at them, but at people whom they have come to dislike. If you have become angry because you like to use the “N-word” and people have criticized you about it, you may have become angry about what strikes you as political correctness.
Other voters are very angry at the lack of progress being made by current career politicians on solving immigration, economic, and other problems. Many of these voters’ own personal style for dealing with this anger is to throw insults at these politicians. When politicians do the same thing, these voters see them as one of them. These same individuals are apparently unable to see that if these politicians were throwing the same types of insults at them, they would not like this. To them, it’s perfectly okay to insult people they have come to dislike. If they are personally insulted, however, then they would view it as wrong. It seems to me that because it is wrong for people to insult them when someone disagrees with them, it is equally wrong for them to insult others when they disagree with others.
Many like to characterize politicians that use insults as their way of being a tough no-nonsense kind of person. But in my view a person can surely be a tough no-nonsense kind of person without seeking to insult people.
When politicians are asked why they use insults, they at times say that those whom they insult, insulted them first. But those who insulted them often say they did it because others insulted either them, or someone they personally know. And so many who are either leaders of our nation, or hope to be so, are choosing to engage in this “You Started it First” name-calling game.
It is simply not true that if someone throws an insult at you the only intelligent way to respond is to seek to insult them back. In my view, within the political arena, one way to respond in a manner that I would respect is to state firmly, “I’m not here to get into this name-calling game. I’m here to let the public know what my positions are on the problems of this nation, and how I, if elected, plan to go about fixing them.”
I hope this post will help you to think twice if you have begun to think that the type of insulting behavior that appears to be helping to get attention from politicians would be just as effective in your own interpersonal relationships.
———————
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional intelligence. To begin at the very first post you can click HERE.
“Blowin’ In The Wind.” “With God On Our Side.” “Masters Of War.” These are songs Bob Dylan has written and performed expressing deep emotions about the wisdom of going to war. As I began to reflect on these songs, to my mind came the pounding of war drums, the cries of vicious insults emanating from a deadly divide, images of fear, pride, disgrace, bombs exploding, and thousands screaming in horror.
And then I found myself pulling up on the internet Bob Dylan’s Theme Time Radio Hour show, and clicking to hear his specific show on the theme of war. It’s available for free HERE.
The show provides a musical meditation on war, along with Bob’s comments and his reciting of little snippets of relevant philosophical thoughts and poetry.
For many, when the topic of war comes up, they see visions of glory. Bob’s show provides a far wider vision, incorporating thoughts and emotions we would be wise to incorporate into our considerations regarding the possibility of further escalations of violent conflict in the coming days. Here are some highlights from this show.
Highlights
The show begins with a series of brief audio clips of the sounds of a country at war–bombs going off as Marine helicopters are approaching a battle field, a news reporter describing the scene of burning tanks, the voice of President Lyndon Johnson committing an additional 20,000 troops to Viet Nam as that war was escalating, etc. Then we hear Bob introducing the show’s theme:
Back to Theme Time Radio Hour. As you know, we cover a lot of ground here, but this week the subject has a greater gravity than usual. Plato once said, “Only the dead has seen the end of war,” and sadly it is as true today as it was then.
Edward Starr said, “War, what is it good for? Absolutely nothing.” That’s not true. War is good for the economy, and for medical and scientific advancements. What it is not good for is people. Blood is spilled too often for too little. Bertrand Russell said, “War does not determine who is right, only who is left.” As General Patton once said, “The object of war is not to die for your country, but to make the other bastard die for his.”
Today we are going to examine battles and beaches, skirmishes and embroglios, we are going to let loose the dogs of war, pay tribute to Mars in Aries, shed a tear for the widows and orphans. We’re mustering cadets, for Theme Time Radio Hour is going to war!
With this, we hear the explosion of bombs. Then Bob tells us, “It’s going to get heavy in here, so while we can, why don’t we start off on a lighter note.”
Johnny Mercer
He then introduces a rather lively, humorous song written by Johnny Mercer, titled, “The G. I. Jive” that makes fun of all of the abbreviations used in the military.
A little later, Bob plays a song by Roy Acuff, “Searching for a Soldier’s Grave.” It’s a real heartbreaker:
Somewhere here among these many soldiers
Of Americans who all died true and brave That’s where I know I’ll find him resting
So I’m here I’m searching for his grave.
You ask me stranger why I made this journey Why I crossed three thousand miles of rolling waves.
Like many others my darling’s killed in action That’s why I’m here I’m searching for his grave Somewhere here among.
When I come to this far where he’s sleeping I know it will cause more heartaches inside But I long to be by his side once more and tell him Tell him that I love him and will until I die.
Of the various songs portraying the bloody scenes of war that Bob plays in this edition of his show, “The Band Played Waltzing Matilda” is the one most graphic:
When I was a young man I carried me pack And I lived the free life of the rover From the Murray’s green basin to the dusty outback I waltzed my Matilda all over.
Then in 1915 my country said: Son, It’s time to stop rambling, there’s work to be done So they gave me a tin hat and they gave me a gun And they sent me away to the war.
And the band played Waltzing Matilda.
When the ship pulled away from the quay And amid all the tears, flag waving and cheers We sailed off for Gallipoli.
It well I remember that terrible day When our blood stained the sand and the water And how in that hell they call Suvla Bay
We were butchered like lambs at the slaughter.
Oh those that were living just tried to survive In that mad world of blood, death and fire And for ten weary weeks I kept myself alive While around me the corpses piled higher Then a big Turkish shell knocked me arse over head
And when I awoke in me hospital bed And saw what it had done, I wished I was dead I never knew there was worse things than dying
Oh no more I’ll go Waltzing Matilda All around the green bush far and near For to hump tent and pegs, a man needs both legs No more waltzing Matilda for me.
And the Band played Waltzing Matilda….
There’s quite a bit more tear soaked lyrics to this song, but you get the general idea.
At one point in the show, Bob shares a particular dislike about one aspect of wars:
Some say war is a game that men play using boys as the tools. Truth to tell, you don’t see many men in battle, but you see a lot of boys. Wars used to be fought by men and I think that fairer. Men are the ones waging the war, they ought go out and fight it.
Bob also has a heart that aches for the soldiers who come home from battle and need a helping hand, showing this by playing for us a song titled, “The Forgotten Soldier.” Here’s a few of its lines:
I’m just a poor ex-soldier that’s broken down and blue, Fought out in the Great War for the old red, white, and blue.
I left my parents and my girl I loved,
To France did go.
And fought out on the battlefield through hunger, sleet, and snow.
I saw my buddies dying, and some shellshocked and torn.
Although we never faltered at the battle of Amarne
And we were told when we left home we’d be heroes of the land,
So we came back and found no one would lend a helping hand.
About half way through the show, Bob tells us:
One staple of songs about war is the letter. Sometimes it’s the letter that the guy writes from the battlefield. Other times it’s from home. But the worse kind of letter of all to receive was one written by a military chaplain. It usually had a line in it, something like, “You would be delighted to know that your son died a hero.” It’s a nice sentiment, but I doubt it was really any solace.
Tom Waits recently wrote a song about a letter to a soldier. Here it is, “The Day After Tomorrow.”
Here’s a few of its touching lyrics.
I got your letter today And I miss you all so much here I can’t wait to see you all And I’m counting the days here….
I close my eyes every night And I dream that I can hold you
They fill us full of lies,
That everyone buys ‘Bout what it means to be a soldier
I still don’t know how
I’m supposed to feel ‘Bout all the blood that’s been spilled Will God on His throne Get me back home On the day after tomorrow
You can’t deny The other side Don’t want to die Any more than we do What I’m trying to say, Is don’t they pray To the same God that we do?
Tell me, how does God choose? Whose prayers does he refuse? Who turns the wheel? And who throws the dice On the day after tomorrow?
As Bob begins to close this show, he tells us, “I wish it was as easy to get to the end of war.” Then he says, “I want to leave you now with this song, because I didn’t want to leave the hour with war talk without giving you the opposing view. I’m going to let Los Lobos do it, and join you in wishing for peace. Stay safe.”
Here’s a few of the lyrics:
Peace to the world
I see a baby in a crib Reaching up for Mama’s arms Love is rising in their hearts, oh yeah.
There is a man standing on the street Shouting loud above the crowd Saying amen to everyone around, oh yeah.
I see a man who loved his land Laying lifeless on the ground He said the time is now To bring peace to the world Say yeah, yeah, yeah Peace to the world
We build a wall of stone As high as the trees are tall Higher then the mountains Stronger then us all, oh yeah
Some day that wall will crumble Tumble and fall, the sun will shine And bring peace to us all.
Conclusion
An American flag waving in the breeze along with stirring patriotic music; this can be a fitting end to a Hollywood movie, but before we go marching once again into war, there is far more to consider.
Bob’s show provides us a magnificent musical, literary march through many of the consequences of war too easily ignored. In the end, Bob has us turning our attention toward promoting peace.
In a recent post (see HERE) I describe five factors that have led to the human race dramatically decreasing its use of violence to settle conflicts. I then describe how a president can coordinate all five of these factors to bring about a more peaceful international situation. It is my deeply felt hope that countries, in coming years, will seek to elect leaders that have the wisdom to utilize these factors for the benefit of not just all of us, but for all of the children yet to come.
——————–
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional intelligence. To begin at the very first post you can click HERE.
I hope all of you are having a fine holiday season. This, of course, is the time of year when the longing for peace on Earth and good will to all is beautifully expressed in songs and stories.
Despite this longing, over the centuries, during the holiday season, for many, it brings a lamenting because we have not achieved this deeply heartfelt desire. For example, during the American Civil War, Henry Wadsworth Longfellow wrote a poem titled “Christmas Bells,” that was later made into a song renamed “I Heard the Bells on Christmas Day.” It begins with pleasant aspects of the season, but then the reality of the war sets in:
“And in despair, I bowed my head; ‘There is no peace on earth,’ I said; ‘For hate is strong, and mocks the song of peace on earth, goodwill to men.’”
Being among those who respect people that take some responsibility for actually doing something to achieve that which is desired, I found myself seeking some way to help bring about a more peaceful world. This post, meager as it is, presents the result of that effort.
It explains why we have every reason to be hopeful that there are constructive things that can be done, and presents the factors that have, over the centuries, led the human race to become more and more likely to resolve our differences peacefully. It then puts forth a vision of how we can combine those peace-promoting factors in a way that just might transform the longing for peace on Earth, good will for our fellow human beings into a set of circumstances that move us steadily closer and closer toward the fulfillment of this beautiful age old desire.
There is Reason to Hope
For people who are absolutely convinced that we have violent genes and therefore there is no hope of changing our violent nature, consider this. In the earliest period that humans thrived, they were chiefly hunters and gatherers. At that time, it has been estimated that death came as a result of one person killing another about twenty percent of the time. Evidence for this was obtained by looking at the skeletons from that period. Quite often we find fractured skulls and arrowheads embedded in chest cavities.
Then came the development to an agricultural civilization with cities and governments, beginning around five thousand years ago. These governments provided rules to resolve some common conflicts in a manner that struck the citizens as somewhat fair. With that, there was approximately a fivefold decrease in rates of violent death.
Next came the consolidation of a patchwork of feudal territories into large kingdoms with a centralized authority to resolve conflicts and an infrastructure of commerce to obtain goods and services peacefully. Violence decreased another tenfold to fiftyfold.
Another dramatic decrease occurred around the Age of Reason and the European Enlightenment in the 17th and 18th centuries. The invention of the printing press had made pamphlets and books far more readily available, spreading humanistic values throughout the human population. That era saw the first organized movements to abolish slavery, dueling, judicial torture, superstitious killings, sadistic punishment, and cruelty to animals.
Now, in most places on Earth, humans have reached a point at which they kill other humans at a rate of approximately 2 per 100,000, a tiny fraction of the amount of earlier times. However, significant sections of the world have not followed a similar developmental trajectory. Since some of these regions have large Muslim populations, many are asking the question, Are Muslims less capable of psychological development?
Actually, we find that the vast majority of Muslims who are living under similar sets of conditions as other religious groups in the developed countries are in no way more violent, nor are they more likely to violate what are now viewed by most as basic human rights. Also relevant to this question is the fact that people from religious groups other than Muslims, when raised under the conditions similar to the violent Muslim areas, are every bit as violent as groups like ISIS. Consider the murder rate in communities like South Chicago.
Today, the major parts of the world that are most violent prone are at the same psychological developmental level as the largely Christian southern states were just about when the American Civil War began. Let us compare, for example, the highly violent group known as ISIS with that bloody period of American history. The confederate southern states had, like ISIS has today, an ideology that slavery was essential to their way of life, and outsiders (the northern states) were actively interfering with what they believed is right. Moreover, the confederate states used quotations from their holy book to defend their beliefs and to justify going to war to protect their ideology in a way that is similar to how ISIS utilizes sections of their holy book.
Now some may believe that the only way to have created the conditions for the confederacy to change their ideology to one more consistent with a higher level of development was to engage them in a horrible civil war. I hasten to point out that in many other places in the world, the slavery ideology changed without a war. In England, for example, certain conditions, such as the availability of literature from the enlightenment age, changed, and its citizens peacefully ended slavery within its own borders.
After abolishing slavery, England continued for about a hundred years to use violent force to maintain its hold on colonial labor, but Mahatma Gandhi effectively used nonviolent resistance to put an end to colonial rule. Soon afterwards, colonialism began to end elsewhere.
I will just add here, that the violent American Civil War actually did little to change the ideology of those who lived in the southern slave states. Rather, it embittered many, and in fact hardened, for many, their prewar positions. This was reflected in how southerners instituted “Jim Crow” laws. In the end, the non-violent approach of Martin Luther King, Jr. proved to be far more effective in creating the conditions for real psychological development in that region of the US.
So, given where ISIS and other violent prone regions of the world are on this theoretical developmental trajectory, let’s take a look at five steps that, when taken together, might be a better alternative to dealing with these areas than violent approaches.
The Five Steps Toward a More Peaceful World
Step1: One of the factors that tends to increase violence is the degree to which some group feels they are being pressured by violent means to act in ways they don’t wish to act. Therefore, one thing that we can do is to reduce the impression that we are seeking to violently control the lives of the people in the regions where violence is terribly high.
There are some credible reasons for supporters of the most violent regions of the Earth to feel that there has been an ongoing effort to force them to do whatever is in the interest of the US and its allies. Years before the creation of ISIS, for example, meddling in Middle East affairs occurred by the US’s CIA. Then came the US invasion of the largely Muslim inhabited Afghanistan and Iraq countries.
So, the first step we, the American people, can do is to advocate that the new incoming US president openly states:
In the past, the US has been involved in using violence in an effort to control some foreign groups. We now realize this causes far more harm than good. Although it took us some time to develop a psychological understanding of this, we are now ready to move forward in a nonviolent manner to promote peaceful ways to cooperate on mutually beneficial agreements.
Taking responsibility for previous harmful actions, and making a commitment to nonviolent ways to achieve common goals, when combined with the other steps described below, would, if we reliably stuck to this policy, provide for all the world a model of what can be achieved in this manner.
Step 2:
With regards to responding to regions that continue to enslave people, the US would use nonviolent approaches such as boycotting any goods or services that might fund the violent group’s operations, along with boycotting any country or enterprise that does business with such violent groups, while offering a vision for engaging in peaceful commerce as described in step 4.
Step 3: As more and more reliable processes are developed that fairly, peacefully resolve conflicts, and the group members view these processes as just, violence plummets. Therefore, the US would launch an all out peaceful advocacy effort to have the United Nations offer to fund a constitutional convention for all of the stakeholders in the regions where violent groups are operating. Those violent groups’ representatives would be invited to be central players, and incentives to participate would be provided. UN Peace Keepers would be employed throughout the convention period to help decrease the likelihood that some would seek to violently sabotage such efforts.
Professor Steven Pinker provides evidence in his book, The Better Angels of Our Nature, that although UN peacekeeping missions, at times, have had their share of failures, when all of the available data is looked at, these missions led to an 80% reduction in the probability of a subsequent war.
Step 4: In step 2 of this proposal, it was mentioned that the US, in response to groups that have enslaving policies, would boycott its commerce as one means to nonviolently encourage a change in policy. It is important to point out, however, that one of the conditions that Professor Pinker has identified as hugely important for the development of nonviolent approaches for resolving conflicts and an increase in respecting basic human rights is improvements in commerce. When people wish to do business with others, they typically seek to improve relationships with them, make them feel welcome, and offer opportunities for shared benefits.
The regions that have the most violent groups have some unique challenges in this regard. And in fact, many believe that it is this set of challenges that is the main cause of the region’s violence problems. In mid-day much of these regions are often so hot it could make the Dalai Lama ignite in irritability. Large sections of these regions are as parched as the moon’s surface. But the regions do have some natural resources. For example, they tend to have plentiful sunshine. Nevertheless, they remain rather poor in contrast to the more developed countries.
Under the plan that I am advocating, the US would work with the United Nations to offer the stakeholders of these regions an opportunity to set up a convention that can tap world experts on economic development with the goal of coming up with plans that are designed to improve sustainable commerce. People from these regions would be invited and incentivized to participate. Once these violent group members come to understand the value of peaceful commerce, and a hopeful plan adopted, many will end up abandoning their violent ideology.
Step 5. One of the major conditions that foster psychological development is the availability of stories that reveal the humanity of people that lie outside our immediate circle of family and friends. Professor Pinker notes that prior to the invention of the printing press there were very few books available. Those people who lived in the upper classes rarely had much direct contact with the lower classes. A nobleman’s quick glance while passing by a downtrodden worker often merely left the impression of a filthy, smelly soul, hardly human at all. After novels became available, a nobleman might read of a poor young woman pressed into very sad circumstances by a cruel person of the upper classes, and discover tears running down his cheeks. Discovering that people all over the world, in all classes, and other religions have very similar desires, dreams, and feelings that we can all relate to, increases empathy and the desire to deal with a wider range of humanity in kind and respectful ways.
So, how would we get these kinds of stories before those who are in groups prone to violence? At the two types of conventions I mentioned above that would be funded by the United Nations (constitutional and commerce) short, readable, relatable books would be freely provided that convey these heartwarming stories. International funding for public libraries for regions too poor to provide for them on their own would be provided. Moreover, there are ways to make these types of stories particularly accessible on internet sites that violent groups tend to visit, not only in written form, but also in audio-visual forms as well. And instead of the steady dropping of bombs in regions occupied by violent groups, an international coalition could drop little parachuted packages that include a little tasty healthy treat, a little toy or stuffed animal as a gift to the children, an interesting puzzle that adults would enjoy doing, and the type of stories that I have just described.
Conclusion
Okay then, there you have it, my proposal for an alternative approach for furthering peace on Earth, good will among our fellow human beings. I know that some of what I described may sound familiar because they have been tried before in a dribs and drabs manner, but with a significant increased support for these efforts, and by combining all of the steps in a systematic, coordinated manner, I believe they just might lead to progress toward achieving the desire for a more peaceful, kind world.
———————————
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional intelligence. To begin at the very first post you can click HERE.
Recently I came upon an article in the October 2019 edition of the American Psychologist about using timeouts with children from 2 to 8 years of age. As a grandfather, it caught my attention.
According to the authors, Mark R. Dadds and Lucy A. Tully, the use of this technique is quite controversial. Well, it just so happens I love dealing with controversial issues. Though it often leads to some nasty insults flying my way, it gives me the opportunity to practice avoiding throwing insults back, and modeling a more respectful style.
The Controversy
What does this controversy look like? Well, let’s begin by looking at an article published in Time magazine titled, “Time Outs Are Hurting Your Child.” Here we learn from the authors, Daniel J. Siegel and Tina Payne Bryson, that:
“The problem is, children have a profound need for connection. Decades of research in attachment demonstrate that particularly in times of distress, we need to be near and be soothed by the people who care for us. But when children lose emotional control, parents often put them in their room or by themselves in the “naughty chair,” meaning that in this moment of emotional distress they have to suffer alone.”
Contrast this position with one expressed in an article published in the Washington Post titled, “Timeouts Get a Bad Rap, But They Work — When Used Correctly.” Its author, Camilo Ortiz wrote, in part:
“The effectiveness of timeouts has been proven through decades of research, including work in the field of “behavioral parent training,” in which professionals teach parents a set of effective techniques. These techniques — a combination of reinforcement of appropriate behavior, effective commands, timeouts and other consequences — are usually used with children who exhibit moderate to severe disruptive behavior, but they have also been shown to be effective with children demonstrating less severe behavior.
Apparently, part of the controversy is due to the timeout technique being employed in different ways. Consider a parent who says she uses time out with her 5-year-old daughter. Then, when we watch her using the technique, we discover that whenever her daughter acts in any way that is annoying her, she begins to scream, shoves her into her room, while shouting, “You better shut-up you little brat!” She keeps her alone in her room for an hour.
Now consider another mother who says she uses timeouts with her 5-year-old son. This time, when we watch what she actually does, we see that she uses it along with a much larger set of discipline techniques that she learned from reading the manualized and evidence-based parenting program titled, The Incredible Years. Because she has a number of tools to teach her child to learn how to behave in effective ways, she only uses timeouts on rare occasions, lasting only 5 minutes, and targeting just one behavior during a period of a few weeks until her child has learned a new positive behavior pattern to replace the negative behavior pattern. Then, slowly, she incorporates the technique for teaching another behavior pattern. She never tells her child to stop doing the negative behavior pattern, but instead, she explains, as best that she can, what behavior pattern would be better, and explains why it would be better. When she sends her child to timeout, she does so in a calm, supportive voice, and remains in the same room with him. Prior to carrying out this approach, she has discussed with her child this technique, explaining that learning a new skill takes time, and timeout will help him to learn to act in a manner people will respect. She emphasizes throughout the process that she loves him, and expresses confidence that he will master the new skill soon.
So, here we see two parents believing they use timeouts with their child, but both use dramatically different approaches. I used timeouts with my two sons when they were very young in an even different way. I’ll describe this other approach shortly, but, for now, my main point in this section is that part of the controversy has to do with the fact that when people say they use timeouts, without finding out more details about how they use it, a great deal of misunderstanding can ensue.
Back to the American Psychology Article
Dadds and Tully, the authors of the American Psychologist article I mentioned at the beginning of this post, say that for them the definition of timeout is, “…a parenting strategy in which a child’s access to rewards, usually parental attention, is temporarily removed contingent upon a problem behavior and reinstated following a specified period of nonproblem behavior.”
Removing access to rewards is a type of punishment, and research on punishment indicates it leads to variable results, sometimes good, sometimes bad. Dadds and Tully appear to hope to mitigate any bad results by advocating that rather than using timeout as a stand alone strategy, its use “must be part of a broader behavior program that promotes a warm and rewarding relationship, and explicitly teaches alternative positive child behaviors to replace the problem behavior to improve the child’s self-efficacy in meeting their own needs.”
These authors, reviewing the research evidence, conclude that timeout, when used as they describe, can promote a child’s mental health and that there is an absence of evidence showing it is harmful after five decades of research. Meanwhile, inappropriate parental discipline strategies have been, and continue to be implemented in the name of “timeout,” and these are potentially harmful.
Now, before moving on, let me be clear that I am not disputing the research findings presented by Dadds and Tully. That said, my wife and I nevertheless used with our two sons when they were young a strategy that I viewed as timeout, but it differed in important ways from their approach. I think that difference is worth considering.
How I Used Timeouts
Like the authors in the American Psychologist article, I used timeouts as part of a broader child rearing strategy. However, unlike them, when I did use it, I did not seek to remove my child’s access to rewards, or any other type of punishment.
I have described my broader child rearing strategy in earlier posts (see HERE and HERE) Very briefly, it involved identifying what I wanted each of my two sons to do better and explaining to each of them why it would be better. If one or the other, did not succeed immediately in doing it just right, and began to resist, sometimes he would flare up in anger. When a situation of this kind occurred and he was all tense and excited, I would drop the subject and direct his attention to something else. Then, a little later on, I would bring it up again when he was in a calm mood. As likely as not, he would go over it now without any difficulty.
Another part of my strategy was, whenever possible, to teach my sons to improve their behaviors by focussing on the notion of a good. As William James, the great psychologist and philosopher, described using this approach with children:
Get them habitually to tell the truth, not so much through showing them the wickedness of lying as by arousing their enthusiasm for honor and veracity. Wean them from their native cruelty by imparting to them some of your own positive sympathy with an animal’s inner springs of joy.
We would celebrate success, rather than punish less than ideal behavior. And we had family meetings to discuss how we could improve how things were going in our home. My wife and I would first ask our sons what plan they suggest to solve a problem. Even if we thought the plan was less than perfect, we would often support giving it a try for a week. Then, if problems of the plan did occur, it would be discussed at the next meeting.
By using our sons’ plans as much as possible, they would be so intent on proving it can work, they would make it work despite flaws. As parents, our goals were to encourage our kids to understand that we were willing to listen to them, and we valued what they had to say. It was also important to us to foster in our boys sufficient self-efficacy in coming up with solutions that they could successfully implement, rather than always relying on authorities.
Finally, I am a big believer in teaching through stories. When an issue came up, I would either rely on a story I had heard, or make one up, designed to help them to consider better approaches to resolve certain problems. And I had both my boys read my three novels that have, embedded in their relatable narrative, a variety of issues regarding kindness and acting in ways that foster respect from others.
Now, because of these approaches, my wife does not recall using timeouts, and I rarely used it. When I would, it was not designed to teach them to improve their behavior. It occurred when someone nearby was having a hard time tolerating something one or both of my sons was doing.
For example, I might come home from work and my wife would say, “Jeff, could you get the kids away from me, I’m preparing dinner and they keep screaming.” So I would take them outside if it was nice out, or up to their room, while explaining, “Mom needs some quiet time.” Then when we would get to the quiet place, I would ask if they wanted some “quiet time” themselves, or did they want me to stay. They always said they wanted me to stay. We would then do something fun.
Note that in contrast to the American Psychologist article I discussed earlier, my use of this type of timeout was not intended to take away some valued reward. Rather, I would seek to do something pleasant with them. At some point, when all was calm, I would ask gently, “When you were making all that noise near Mom, had she asked you to quiet down?” I would then listen to their responses and gently ask what they could do better if a similar situation comes up in the future? When they were very young, sometimes they blamed someone other than themselves for what happened, and I would frown. Sometimes they responded in a manner that took responsibility for their actions, and I would say how much I appreciated what they had said.
As another example, when we were in a restaurant, if one of my boys began to make too much noise, I would take him outside, and explain that people who go to restaurants typically prefer to eat in a pleasantly quiet atmosphere. I would then explain that when he was ready to go back and speak softly we could enjoy a nice family meal together. Typically, in less than five minutes, we would be back at our table.
Now, what I just described, was the general discipline plan. That said, neither I, nor my wife always stuck perfectly to it. We did pretty good, but we both did lose our temper from time to time. When calm returned, I would say at a family meeting that I wished I had handled the situation better. I would also explain that sometimes even adults are not always perfect, and when I raised my voice in anger, if they thought it meant I don’t love them, actually I love them a whole lot.
Let me be crystal clear, I do not have any research evidence that suggests my approach is distinctly better than any of the others that uses timeout along with a broader discipline approach. All I can say for it is that it felt more right to me as I went through the period of my life when I parented on a daily basis, and though I’m obviously biased, as far as I’m concerned, both my boys, now in their thirties, turned out to be fine young men.
Well, there you have it, some thoughts on the controversy surrounding timeouts. I hope you find something helpful in some of the ideas that I shared, and please feel free to share your ideas with me and all of the followers of this blog.
Jeff
——————————-
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional and social intelligence. To begin at the very first post you can click HERE.
Welcome to From Insults To Respect. Today’s topic involves life and death issues.
When some people become concerned about their emotions, moods, behavior, or the ups and downs of life, they often seek professional mental health services. If they go to someone in the medical profession, they typically find that after a visit of somewhere between ten minutes to an hour they have been labeled as having a mental disorder and then are prescribed one of the psychiatric drugs, or even a whole cocktail of them. This pattern of dealing with such concerns leads, in some circles, to a conflict. Some involved in the conflict think that the pathologizing of these very human experiences and the encouraging of the use of drugs to manage them is the very opposite of a healthy approach. Meanwhile, other people feel that drug treatment for these types of concerns are enormously helpful, and anyone questioning this position is irresponsible. Insults have been known to fly back and forth from people on both sides of this conflict.
Now it just so happens, I have extensive training in the biological, psychological, social, and cultural factors that influence emotions, moods, and behavior. I have also taken specific coursework in psychopharmacology, statistics, and evaluating research methodology. To my dismay, after studying the relevant research, I have found that the current psychiatric medical approach for addressing these types of concerns appear to be causing far more harm than good. Please don’t misunderstand me. I do think the medical model can be enormously helpful when it comes to treating such problems as lesions, tumors, microbe infections, bone fractures, tissue tears, and body organ blockages. It is the psychiatric medical model that I have found seriously flawed. You can hear me, for free, being interviewed on this topic by the insightful Emily Whyte Rubin on a recently recorded Feeling Deeply podcast by clicking HERE.
Whenever I share my conclusions on this topic, I have found, at times, insults flying my way. This occurs even though I really don’t have a conflict with those who accept unquestionably the medical model for addressing psychological concerns.
You see, when I look to see if someone has a conflict, I think of the word DIG. This reminds me to dig to find what the person DESIRES in this situation, what is INTERFERING with the person’s desire, and whether or not the person believes someone is GUILTY of doing something wrong.
Being guilty, as I use the term, means the person would be deserving of some punishment, such as being insulted.
So, from my perspective, I do have a desire-incompatibleproblem with those who support the psychiatric medical model because I desire that they stop pathologizing these concerns and stop advocating that people take psychiatric drugs. However, I don’t view them as guilty for the position that they have come to accept. I believe that they mean well. I seek to treat them respectfully, while doing my best to advocate that they change their minds.
That’s not to say that I advocate that those people already taking these drugs should immediately stop taking them. There are some physiological withdrawal effects that occur if someone suddenly stops, which some experience as awful. If some of you who have been taking these drugs decide that you want to try to wean yourself off, a good resource to help can be accessed HERE.
Although I don’t have a conflict with those who believe in the psychiatric medical approach, I do find that as I go about advocating for my own view on this issue, many with opposing views do end up having a conflict with me.
There are, however, other people who do support the psychiatric medical model, and yet, like me, treat people with opposing views respectfully. Today’s post comes out of one such respectful discussion. This person, without insulting me, defended his support of the psychiatric drugs by claiming that all of the research clearly indicates that the “antipsychotic” drugs, when used by people diagnosed as having schizophrenia, decrease the risk of dying. I then, very respectfully, asked that he supply me with the references that he is relying on to make his assertion, and within a very brief period, he did just that.
Since this is a public forum, and since I will be critiquing his position, it strikes me as unkind to mention his name. However, despite this being a public forum, I do invite him, and anyone else, to critique anything I say in this, or any of my post.
With that said, let us move on to my critique.
What Evidence Exists For Informing Us As To Whether or Not These Drugs Reduce The Risk of Dying
Prior to looking at the articles that the respectful criticizer of my position provided to defend his belief that the “antipsychotics” reduce mortality for people being treated for schizophrenia, let’s first look at some relevant research studies that he left out. You will note that each time I use the term “antipsychotics” I put it within quotation marks. This is to help remind readers that these drugs do not work like antibiotics, which are designed to kill bacteria that have infected an organism. Nor am I at all convinced that these drugs work to counter any of the causes that lead someone to be given a psychotic label.
The Studies That Were Left Out
Patients diagnosed as having schizophrenia have a 15-20 year shorter life expectancy than the general population, according to a 2014 study published in the Annual Review of Clinical Psychology titled “Excess Early Mortality in Schizophrenia.” Just in case there is any confusion of what “mortality” means, it means risk of death.
Earlier studies suggested that part of the reason for these early deaths might be due to the “antipsychotic drugs” that these patients are prescribed. For example, in 2006, the British Journal of Psychiatry published an article titled “Schizophrenia, Neuroleptic Medication and Mortality.” “Neuroleptic medication” is another name used to refer to “antipsychotics.” The authors found that over the 17-year follow-up period of their study there was a graded relationship between the number of “antipsychotic” drugs prescribed and mortality of those with schizophrenia.
Adjusted for age and gender, people with schizophrenia taking either no “antipsychotic,” one, two and three or more antipsychotics had relative mortality risks of 1.29, 2.97, 3.21, and 6.83 respectively. Said in a simpler manner, individuals who were labelled as having schizophrenia who did not take any “antipsychotic” drugs had the least chance of dying during the 17-year follow-up period, compared to the other patients who were labeled as having schizophrenia but were taking “antipsychotics.” If the patients took just one of the “antipsychotic” drugs, they were more likely to die, and if they took more than one “antipsychotic” drug, they were even more likely to die. The association remained stable throughout the observation period.
The authors note that it has been claimed that the contemporary high natural mortality in schizophrenia results from a variety of lifestyle factors. Of these factors, the study that they did was able to consider several (smoking, exercise, body mass index, blood pressure, serum total and HDL cholesterol). After adjustment for these factors the excess mortality of people with schizophrenia persisted. The association with “antipsychotics” and mortality was, according to the authors, very clear.
A 2007 study was published in the Archives of General Psychiatry titled “A Systematic Review of Mortality in Schizophrenia: The Differential Mortality Gap Worsening Over Time.” The authors wrote:
Mental health services have advanced in many parts of the world during the past few decades. Apart from a different mix of community-based care, the introduction of the second-generation antipsychotic medications [also referred to as atypical antipsychotics] in the early 1990s was initially found to be associated with better quality of life and reduced risk of relapse.77–79 More recent trials have questioned the clinical superiority of second-generation antipsychotic medication,80,81 and concern is now widespread about the adverse effects associated with these medications.82 In particular, compared with typical antipsychotics, several of the second-generation antipsychotics are more likely to cause weight gain and metabolic syndrome.83 Because the metabolic syndrome is associated with a 2- to 3-fold increase in cardiovascular mortality and a 2-fold increase in all-cause mortality,84 these adverse effects would be expected to contribute to even higher SMRs [Standard Mortality Ratio] in the next few decades.85,86
During the 1970s through the 1990s, the authors note, mortality rates were improving for the general population. In contrast to this general trend, mortality of those classified as having schizophrenia was trending in the opposite direction. The median SMR for those diagnosed in the 1970s, 1980s, and 1990s were 1.84, 2.98, and 3.20, respectively. The higher the SMR, the higher the rate of mortality.
This study also indicates that the use of “antipsychotics” that are prescribed for people diagnosed as having schizophrenia is least for the least developed countries, while countries with emerging economies use a little more, and the developed countries use the most. Here are the SMRs for these patients: the median all-cause SMRs for least developed, emerging economy, and developed countries were 2.02, 2.19, and 2.79, respectively.
The authors conclude,
Adverse health outcomes associated with weight gain and/or metabolic syndrome (eg, myocardial infarction, cerebrovascular accidents, or cancer) may take decades to fully emerge. Thus, it seems likely that studies undertaken in the 1990s (ie, the most recent studies included in this review) would capture only a small fraction of the eventual burden of mortality associated with the adverse effect profile of the second-generation antipsychotic medications. In light of the rising secular trends in SMRs already identified by this review, the prospect of further increases in mortality risks for schizophrenia is alarming.
The following year, 2008, a study published in the journal Epidemiologic Reviews, titled “Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality,” found further evidence that supported the 2007 Archives of General Psychiatry concerns.
In 2009, another study looked at the relevant research, this one appearing in the journal Schizophrenia Research. Titled, “Influence of Antipsychotics On Mortality in Schizophrenia: Systematic Review,” it concluded, “There is some evidence that long-term exposure to antipsychotics increases mortality in schizophrenia. More rigorously designed, prospective studies are urgently needed.”
Also in 2009, there was a relevant study published in the prestigious New England Journal of Medicine. Titled, “Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death.” It first reviews the relevant research regarding the “typical” antipsychotic drugs and concludes that there is extensive data linking them to an increased risk of sudden cardiac death. It then notes that less is known about whether the same risk is associated with the newer second generation “antipsychotic” drugs often referred to as atypical antipsychotics. After doing the best that these researchers could do to match the users of this type of drug with those who were not users, they found that the atypical drugs had an adjusted rate of sudden cardiac death that was twice that for nonusers and that this did not differ significantly from the rate for users of the typical “antipsychotic” drugs. Moreover, users of each of the six most frequently prescribed antipsychotic drugs had a significantly increased rate of sudden cardiac death, and the risk of sudden cardiac death increased with an increasing dose among current users of typical or atypical antipsychotic drugs.
The researchers conclude, “Our data show that in a large retrospective cohort of adults, current users of the atypical antipsychotic drugs had a dose-dependent increase in the risk of sudden cardiac death that was essentially identical to that among users of the typical agents.”
The researchers mention some limitations of their study:
The primary limitation of our study is the potential for confounding by factors associated with the use of antipsychotic drugs. For persons with serious mental illness, these factors include cardiovascular and other somatic disease; concurrent use of other proarrhythmic medications; mood disorders; behavioral risk factors, including substance abuse, poor self-care, and smoking; and other effects of mental illness.12 However, both the study design and analysis included several provisions to manage confounding.
In 2010, the British Journal of Psychiatry published a study titled “Twenty-five Year Mortality of a Community Cohort with Schizophrenia.” Here, data from 1981 to 2006 was examined. The authors concluded that:
This study suggests that the natural cause mortality of schizophrenia is increasing, a finding that must be of concern to everyone involved with this disease. Further large-scale long term follow-up studies are needed to establish the reasons behind this increase and to suggest useful interventions.
So, taken together, these studies express concern about patients classified as having schizophrenia dying at an earlier age than the general population. Moreover, because the newer generation of “antipsychotics” are more likely to cause weight gain and metabolic syndrome, clear risk factors for increasing the risk of early death, the theory that the “antipsychotics” may be a significant factor for some of these early deaths has been discussed in several peer reviewed journals. Several studies provided evidence for this theory.
The Studies That Were Cited By The Person Who Criticized My Position
Recall that what prompted the respectful critique of my position was my opinion, derived from reviewing the research, that the “antipsychotics” appear to cause more harm than good, particularly in the long run. As science writer Robert Whitaker summarizes this research:
“The drugs are supposed to provide the benefit of reducing psychotic symptoms. But the research reveals that, over the long term, this benefit turns into a negative, and so, over the long-term, there are only negatives to be chalked up: the increased chronicity of psychotic symptoms, the impaired functional outcomes, the worse cognitive functioning, and, of course, a broad range of “side effects,” such as tardive dyskinesia, metabolic problems, sexual dysfunction, and so forth. Such is the bottom-line arithmetic that makes the case against antipsychotics.”
For a free PDF that fully reviews the evidence for Whitaker’s above statement, see HERE.
At the time that I heard from my respectful criticizer, I had really not fully examined the existing evidence that bears on his theory that this class of drugs actually decrease the risk of dying.
Robert Whitaker
My first approach to looking into this was to contact Robert Whitaker to see if he had heard about that theory and whether he knew of any evidence to support it. He replied:
I intend to write about this idea that antipsychotics reduce mortality as soon as I get time. Antipsychotics of course cause all sorts of adverse effects associated with increased mortality. Bob
Disappointed, but undeterred, I decided to do a Google Scholar search to see what relevant research studies I could find, and above I summarized the evidence that the drugs actually increase the likelihood of a person dying. Then I retrieved all of the studies that my respectful criticizer provided that he said supports his contention. Below, I shall critique each and every one of them. But in doing so, the length of this post becomes quite a bit longer than most of my readers are willing to read. So, for their sake, I will first summarize the whole group of them, and for readers who want to delve into my critique of each specific study mentioned by my respectful criticizer, they can do so.
My Summary
The first study on my critic’s list used a meta-analysis approach that looked at 596 studies, all of which looked at patients that were randomly assigned to either an “antipsychotic” or a placebo for 13 weeks or less. For the patients in this analysis that had been labeled as having schizophrenia, there was no statistically significant difference in mortality between the two comparison groups.
Upon reading this article, I was left puzzled as to why this article was included in my critic’s list. As I have said, his contention was that every research paper published demonstrated “antipsychotics” decrease mortality for schizophrenia labeled individuals. Rather than supporting his position, this article supports the theory that given the evidence that the “antipsychotic” drugs have a number of serious side effects, and once started, physiological withdrawal effects can be awful, it is prudent to safely hold off on the use of these drugs for at least 13 weeks to see if some patients will begin to recover without them. Despite this evidence, I am under the impression from dialogues with many psychiatric patients that the standard practice is to prescribe these types of drugs within somewhere between 10 minutes to an hour after the patient is first brought to the attention of a prescribing doctor.
Before moving on, I would like readers to note that this was the only randomized controlled study on my critic’s list of references that he said supports his position. The rest of the studies compared different groups of patients that were not randomly chosen to be in each of the groups. These studies compared a group of patients described as not taking “antipsychotics,” with others said to be either taking just one of them, more than one, different dosages of them, or another drug such as a benzodiazepine. Without random placement to each of the groups, these studies, from a scientific point of view, cannot speak to whether it was the prescribed drug that was the cause of the different rates of mortality, or other reasons. This is an essential point to keep in mind.
Even when a study does have random assignment to each of the different comparison groups, it is quite common that when researchers try to replicate its findings by doing another similar study, very different results occur. This inability to always replicate such studies occurs for a variety of reasons. First, random assignment only increases the likelihood, but does notguarantee, that the different groups being compared will be so similar prior to any intervention that any difference found after the intervention is due solely to the different interventions each group does or does not receive. Thus, with random assignment the pre-intervention groups can end up quite different. When this happens, the researchers can end up attributing any difference between the groups after the intervention to the intervention when the difference might be due to the groups being poorly matched prior to the intervention. A second reason why random assignment studies are not perfect is, those who did the experiment may report the results incorrectly because of a mistake, subconscious biases, or monetary motivations that lead to bending the truth.
Now, I am not faulting researchers for trying to get some relevant evidence using the nonrandom assignment to groups methodology. Although random assignment to groups is considered the gold standard, carrying out long-term studies with psychiatric patients is almost impossible. Patients who are assigned to take the drugs often don’t take them, or don’t take them as prescribed, and the longer the study, the more likely this will happen. A significant number of patients wander off and can’t be found at various follow-up points. Many doctors refuse to participate in long-term studies that utilize a placebo group believing it is unethical to withhold a promising treatment for such a long period of time when they see their patients suffering; and over the decades newer, more promising interventions come along, so to continue to use the drugs that were popular at the start of the study would be considered unethical.
So, given the absence of long-term random assigned studies, some weaker methodologies make sense but it is crucial to be very tentative in drawing any conclusions.
The most important finding from the set of nonrandom to groups studies my critic provided, from my perspective, came out of a 2009 study. There we find that patients that were on “antipsychotics” for less than 6 months had a lower rate of dying than those who were on the drug for longer periods. The authors note this in the results section of their article with a single sentence, stating,”Patients who used antipsychotics for less than 6 months had especially low mortality rates.” This is accompanied by a graph showing this. Then, in the discussion section, the authors again mention this in a single sentence.
If you read just the abstract of the article, as many practitioners do because time reading research studies is not billable, you would find no mention of this statistically significant finding, a finding that could have life saving implications. And this finding can easily get lost in the numerous paragraphs of the study which focused instead on the evidence that those on the drugs for longer periods had a lower mortality than those who were said to be in the “no antipsychotic group.” However, the vast majority of the patients said to be in the “no antipsychotic group,” and probably all of them, actually were on these drugs at various points throughout the study. While they were hospitalized, they were almost certainly on the drugs, according to one team of researchers who had engaged in a similar study using the same data set, and many were hospitalized multiple times. What the researchers actually meant by labelling the group the “no antipsychotic group” were patients who didn’t take them each time they were released from the hospital. Thus, each time they left the hospital, they were suffering from withdrawal reactions.
There are a number of other serious problems with the design of these types of studies that was chronicled in a peer reviewed article that came out shortly after the 2009 study, including incomplete reporting of data, questionable selection of drug groups and comparisons, important unmeasured risk factors, inadequate control for potentially confounding variables, exclusion of deaths occurring during hospitalization leading to exclusion of 64% of deaths on current “antipsychotics” from the analysis, and survivorship bias due to strong and systematic differences in illness duration across the treatment groups. The writers of this critique concluded:
It is likely that many of these patients died from the effects of suicide or cardiovascular disease while admitted to a hospital. As this approach likely underestimates mortality in patients treated with antipsychotic medications, this critical methodological factor might help to explain why the previous literature arrived at different findings with regard to antipsychotic-related mortality risk.
Another huge problem with these types of studies is this: 90% of the patients at the end of them were still living. Thus, it is very possible that although a relatively higher percentage of patients not taking “antipsychotics” during periods when they were not in the hospital died when compared to the other patients during the five to eleven year periods that were looked at during the course of these studies, we still don’t know what would have happened if we could have looked at what age all of these patients ended up dying. The added risk factors that come with ingesting these drugs, such as weight gain and metabolic syndrome, may not exert their influence on mortality rates until a longer period of time.
And yet another major problem with concluding from these studies that the “antipsychotics” reduce the risk of dying is this: It appears from one of these studies that schizophrenia patients during the time frame looked at had no increased risk of having a diagnosis of treatable nonfatal ischemic heart disease or cancer but had a far greater risk of dying from these conditions, suggesting substantial underdiagnosis and/or undertreatment.
This presents the theory that when compared to those patients in the other comparison groups, the group of individuals who did not take “antipsychotics” when they were not hospitalized may have had a higher percentage of members who not only avoid “antipsychotic” treatment, they also avoid all medical treatment. With this theory, it is not taking the “antipsychotics” that protects the patients from dying, but rather it is the increased likelihood that more “antipsychotic” compliant patients are more likely to comply with all medical treatment. Said another way, with this theory, we have less of a reason to conclude “antipsychotics” provide some protection from dying from these conditions; rather, it is this non-compliance to all medical treatment characteristic of some in the “no antipsychotic” treatment group that is the real cause for the statistical increased rate of death for those in this group during the relatively short window of time that these researchers were able to peek into.
In considering how dependable the evidence is from this entire set of studies, it is worthwhile to look how frequent they came up with contradictory findings. A few of the studies, for example, found a statistically significant decreased risk of suicide for those taking “antipsychotics” when compared to the so called “no antipsychotic” group, while another study that looked at the same data set found no significant difference. One study found a significant reduction in risk of dying when the patients used the “antipsychotic” clozapine, whereas another study did not find this, and found instead that clozapine was one of the drugs that appeared to slightly increase the risk of dying. A couple of studies found that even patients who took the highest doses of “antipsychotics” had a similar risk of dying when compared to a moderate dose, while another found the highest dosed patients were at an increased risk of dying. Thus, anyone making firm conclusions based on these types of studies is trying to build a house on shifting sands.
One finding in the set of studies provided by my critic is that a common way to prescribe “antipsychotics” is to prescribe it along with a benzodiazepine, a pill that has some similarities to ingesting alcohol. In one study, nearly 40 percent of the patients were prescribed a cocktail of both drugs, and these patients had a statistically higher likelihood of dying than those who were just prescribed an “antipsychotic.” Making the case stronger that the benzodiazepines were causing the increased risk of death was that the higher the dose of this drug, the higher the rate of mortality.
So, my very tentative conclusion is that the weight of the evidence suggests that in the short run (13 weeks or less) the “antipsychotics” do not significantly affect mortality rates for patients labeled as having schizophrenia. Those patients who are on “antipsychotics” for more than 6 months are at a statistically significant increased risk of dying compared to those who were on this type of drug for shorter periods. There is some weak evidence that “antipsychotics” may provide some protection from dying for those patients taking them for periods of from 6 months to less than 11 years when compared with patients who come off the drugs each time they leave the hospital, but interpreting this statistically significant finding in that way is highly problematic for the numerous reasons that I mentioned above. For patients taking these drugs for longer periods of time, the available data suggest real concerns that these drugs significantly reduce the lifespan of patients.
Finally, all of the studies that provide some support for the theory that, “antipsychotics” reduce the rate of death had researchers with either pharmaceutical company conflicts of interest or were members of departments of psychiatry, the very profession that relies heavily on earning income by prescribing these drugs. It seems to me that given that the issues being studied have life and death consequences, there is an urgent need for high quality studies that are carried out by epidemiologists with no ties to psychiatry or the pharmaceutical companies.
I now provide a description and critique of all of the studies provided by my respectful criticizer.
First Study
The first study that appears on his list was published in The Lancet in 2018, and titled “Second-generation Antipsychotic Drugs and Short-term Mortality: A Systematic Review and Meta-analysis of Placebo-controlled Randomized Controlled Trials.” It utilized a meta-analysis approach that looked at 596 studies, all of which had patients that were randomly assigned to either an “antipsychotic” or a placebo for 13 weeks or less. Here’s how its authors summarized their findings:
Overall, and for the main indication of schizophrenia, there is no evidence from randomised trials that antipsychotic drugs increase mortality. However, vulnerable populations (particularly patients with dementia) might be at increased risk. This meta-analysis could only address acute treatment effects leading to death in the short-term, and not long-term effects of antipsychotic drugs on mortality.
Second and Third Study
These two studies were carried out by the same team of authors and applied a similar methodology using a data base from Finland. The first of these is titled, “Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of Patients in Community Care After First Hospitalisation Due to Schizophrenia and Schizoaffective Disorder: Observational Follow-up Study,” and was published in 2006 in the British Medical Journal. It looked at a nationwide cohort of 2230 consecutive adults hospitalized for the first time because of schizophrenia or schizoaffective disorder, from January 1995 to December 2001. All of the patients had been hospitalized at various points in time, and during their hospitalization, no record was kept to see if while they were there they had been placed on antipsychotics and/or other drugs. Those patients who chose not to fill their prescriptions whenever they left the hospital were said to be in the no antipsychotic group. However, it is very possible that many of the patients in this group had repeatedly gone into a hospital for various periods of time and while there were placed on an “antipsychotic,” or a cocktail of “antipsychotics” and other drugs, and each time they were discharged they went through drug induced withdrawal reactions.
As we will see, there is a number of other serious problems with this study, but let’s get to the authors of this study’s conclusion:
Patients who currently took any antipsychotic drug had decreased mortality compared with the no treatment group. However, not using antipsychotic drugs may be a marker of other conditions that affect the risk of mortality.
Moving on to the other Finland study by this team of authors, it was published in 2009 in Lancet and titled “11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).” As I mentioned, it is very similar to the previous Finland study, but extends the follow-up period an extra few years. Both studies have very similar results. Those who are labeled as not using any “antipsychotics” but probably did use them when they were in the hospital, had relatively higher rates of death than most of the other comparison groups. However, the patients that had the lowest rate of deaths were those in the group labeled as using “antipsychotics” for less than 6 months. In the main body of the journal article the authors note this in a single sentence, stating,”Patients who used antipsychotics for less than 6 months had especially low mortality rates.” There is a graph that illustrates this. It does repeat this again in another single sentence in the “Discussion” section of the report. Nothing else in the write-up of the report bothers to discuss this, and it can easily get lost in the numerous paragraphs defending the evidence that those on the drugs for longer periods had a lower mortality than those who were in the “no antipsychotic group” even though all of those patients in that group had probably been on such drugs each time they were hospitalized, and were only not taking them each time they were released from the hospital.
Dr. Jari Tiihonen
Note that the lead author of both of these articles is Dr. Jari Tiihonen. In the conflict of interest section of these studies it indicates he has served as a consultant, adviser, or speaker for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-La Roche, Janssen-Cilag, Lundbeck, Novartis, Organon, Otsuka, and Pfizer, which are all major pharmaceutical companies.
Dr. Tiihonen, along with the other authors of the article, did mention that although this study lends some support for the theory that, “antipsychotics” may lead to a reduced rate of mortality over an 11-year period, “a longer time might be needed for some adverse events to become apparent.” I applaud them for recognizing this.
Now, I can certainly understand why my respectful critic included these two articles on his list because it appears to offer some support for his position. That said, I am puzzled why he did not include the powerful critique of them that appeared after the 2009 study. It is titled, “Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study,” and appears in the peer reviewed journal Schizophrenia Research. Although it says in the title that it is critiquing the 2009 FIN-11 study, in the body of the article it notes that the same problems exist in the 2006 article. What are those problems? Here’s a summary that appears in the critique:
A number of methodological and conceptual issues make the interpretation of these findings problematic, including incomplete reporting of data, questionable selection of drug groups and comparisons, important unmeasured risk factors, inadequate control for potentially confounding variables, exclusion of deaths occurring during hospitalization leading to exclusion of 64% of deaths on current antipsychotics from the analysis, and survivorship bias due to strong and systematic differences in illness duration across the treatment groups….
It is likely that many of these patients died from the effects of suicide or cardiovascular disease while admitted to a hospital. As this approach likely underestimates mortality in patients treated with antipsychotic medications, this critical methodological factor might help to explain why the previous literature arrived at different findings with regard to antipsychotic-related mortality risk (Osborn et al., 2007; Weinmann et al., 2009).
Arguably, the biggest problem with the two studies that used the Finland data is this: 90% of the patient’s at the end of this study were still living. Thus, we still don’t know what would have happened if we could have looked at what age all of these patients ended up dying.
Finally, given the life and death importance of this study, I can’t help wondering why the country of Finland did not hire epidemiologists with no ties to psychiatry or the pharmaceutical companies to carry it out.
Fourth Study
The next study on my critic’s list is titled “Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study” and was published in a 2016 edition of the American Journal of Psychiatry. The lead author is, once again, Dr. Jari Tiihonen, the same researcher of the last two studies that we looked at and who has numerous pharmaceutical industry conflicts of interest.
Using a very similar methodology as the Finland studies, it found that over a period of 5 years the prescription of moderate or high-dose “antipsychotics” for people labeled in Sweden as having schizophrenia was associated with lower overall mortality, compared to those said to be in a “no antipsychotic” group.” For those prescribed a benzodiazepine along with an “antipsychotic,” the results were quite different in that this group had the highest likelihood of dying when compared to the other groups. Thirty-eight percent of the patients were prescribed a benzodiazepine. Common benzodiazepines are Valium (diazepam) and Xanax (alprazolam).
The problems with the study in concluding that these drugs protect people from dying are similar to the others carried out with Dr. Tiihonen. There were no randomization to groups. “Antipsychotic” drugs that may be used in hospitals were not recorded in the Prescribed Drug Register used to estimate drug use. Many of the patients in the group said to be not using “antipsychotics” very likely used them each time they went into the hospital, and each time they left the hospital they stopped using them and thus went through an awful withdrawal reaction.
There is also a concern about whether or not those patients included in groups said to be taking “antipsychotics” actually ingested them. Taking “antipsychotics” was assumed because someone, either the patient, or a family member, picked up the prescription at a pharmacy. In Sweden there is no financial cost for patients who pick up these drugs. There may have been some incentives to pick up the drugs, but once they were picked up, the patients may have tossed them in the garbage, or simply forgot to take them.
Also, as in the other two studies with Dr. Tiihonen as lead author, over 90% of the patient’s at the end of this study were still living. Recall that in the 2014 study that was not on my respectful critic’s list of references, over the course of 17 years schizophrenic labeled patients taking “antipsychotics” had died at a higher rate than those not taking “antipsychotics.” This provides some tentative support that it might take longer than 5 years, or even 11 years, before it becomes evident that patients that are on these drugs are more likely to die at an earlier age than those who don’t take them.
Given that this study was carried out after Dr. Tiihonen had done an earlier study that found patients on an “antipsychotic” for less than 6 months had the lowest likelihood of dying, it is of deep concern to me that he did not insist that his team do a similar analysis with this Sweden set of data. Could the reason be due to his conflicts of interest with the pharmaceutical industry? The loss of revenue for pharmaceutical companies that would occur if it became standard practice to not prescribe “antipsychotics” for longer than 6 months, rather than the current policy of prescribing it for an entire lifetime, would be enormous.
Fifth Study
This one was published in 2011, appears in the American Journal of Psychiatry, and is titled, “A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia.” The lead author, once again, is Dr. Tiihonen, and it looks at the same Finland data base that we discussed under the heading, “Second Study” and “Third Study.”
The major focus of this article was on comparing two groups of patients that took an antipsychotic either orally, or in the form known as “depot,” which is an injection given in a carrier liquid that releases it slowly so it lasts a lot longer. The authors looked at a period of approximately two years after initial discharge in the hospital. Many of the patients went in and out of the hospital at various times during this period, so those who are said in the study to be in the group that did not take “antipsychotics” were probably on it before they were initially discharged, and probably on them again during each of their rehospitalizations. As the authors duly note, “No information was available on the medications used in the hospital, but it can be assumed that virtually all patients had received some kind of antipsychotic treatment.” Nevertheless the authors report that the “no use antipsychotic group” had a higher risk of dying.
The problems with this finding are largely the same ones that we discussed regarding the other articles that Dr. Tiihonen served as lead author.
Sixth Study
This 2010 study, titled “Antipsychotic Polypharmacy and Risk of Death From Natural Causes In Patients with Schizophrenia: A Population-based Nested Case-Control Study” was published in the Journal of Clinical Psychiatry. It was conducted using data from Denmark. I’m not sure why my critic included this study on his list because it does not address the issue at hand. All of the subjects were on “antipsychotics” and the only relevant finding was that those who were on “antipsychotics” and benzodiazepines were at an increased risk of dying.
Seventh Study
This 2013 study, titled “Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study,” was published in the American Journal of Psychiatry. It is pretty much the same type of study as the one’s carried out with Dr. Tiihonen and uses the same Swedish group of patients over a very similar time period as one of his studies, but here a different team of researchers looked at that data set. Again, lack of antipsychotic treatment was associated with elevated mortality. However, as hard as I looked in the article to see how the researchers defined “lack of antipsychotic treatment” I was not able to find it. As in other similar studies, most of those in the “lack of antipsychotic treatment group” were still alive, so we don’t know if they would, as a group, have begun to die at an earlier age if all were followed up until all in their group died.
Again my frustration is aroused because this study did not look to see if these patients from Sweden who were on “antipsychotics” for only 6 months or less were among those that were least likely to die, as was found by those who did look at this in the Finland data that we discussed above.
This study does add several additional relevant information than those we have so far discussed. First, in this large national cohort study, the leading causes of death were ischemic heart disease and cancer. However, schizophrenia patients had no increased risk of having a diagnosis of treatable nonfatal ischemic heart disease or cancer but had a far greater risk of dying from these conditions, suggesting substantial underdiagnosis and/or undertreatment.
This presents the theory that the group of individuals who did not take “antipsychotics” may have had a higher percentage of members who tend to avoid all medical treatment than the other comparison groups. With this theory, we have less of a reason to conclude that “antipsychotics” provide some protection from dying from these conditions; rather it is this special characteristic of some in the “lack of antipsychotic” treatment group that is the real cause for the statistical increased rate of death for those in this group during the relatively short window of time that these researchers were able to peek into.
This Swedish data is also useful for highlighting that these non-randomly assigned to groups studies can find some remarkably different results when looking at the same set of questions. Thus, in the Finland study, the lowest risk of death was associated with the “antipsychotic” drug clozapine; whereas in the Sweden study the authors reported, “we did not confirm that study’s finding of decreased mortality with clozapine, which was associated with a nonsignificant, modestly greater mortality in our study.” Moreover, unlike the Finland study that had found a statistically significant increased risk of suicide for those in the “no antipsychotic drug group,” in this Sweden study there was no significant increased risk in suicide for patients in their “lack of antipsychotic treatment group.”
Eighth Study
This 2017 study, titled “Reduced All-Caused Mortality With Antipsychotics and Antidepressants Compared to Increased All-Cause Mortality with Benzodiazepines in Patients With Schizophrenia observed in Naturalistic Treatment Settings,” was published in Evidence-Based Mental Health. This study examined the same Sweden data set as our “Fourth Study,” but utilized a different set of researchers. The outcomes were largely the same. Five years were looked at. Compared to the “no antipsychotic” group, the prescription of “antipsychotics” for people labeled in Sweden as having schizophrenia was associated with lower overall mortality, unless they were also prescribed a benzodiazepine, in which case they had the highest likelihood of dying. As in the earlier Sweden study that I discussed, inferences from this study’s findings are limited due to lack of randomization to the various comparison groups which prevent differentiation of causal from non-causal associations. This study actually does not really compare patients who took no “antipsychotics” with those who did, because all of the patients took “antipsychotics” at various points in their lives. Despite statistical adjustment for some relevant baseline variables, highly relevant variables were unaccounted for, including direct measures of schizophrenia severity, unhealthy lifestyle behaviors, degree of substance use, medical comorbitities and treatment, health service use pattern, and treatment adherence. And, of course, the study just looked at what could be observed in a five year period at which point the vast majority of the patients studied were still alive. Such studies don’t reveal what the average age of death is for those who are labeled as having schizophrenia and are taking “antipsychotics” versus those who were also labeled as having schizophrenia but did not take “antipsychotics.” Like other studies that were done after the 2009 study, this one did not bother to find out if patients that were on “antipsychotics” for less than six months was the group least likely to die during the followup period.
Ninth Study
This 2017 study, titled “Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson’s Disease in Nursing Homes,” was published in the Journal of the American Medical Directors Association. It looked at some data over a period of 18 months and does not directly address the issue under discussion. That is, these patients were elderly and had Parkinson’s Disease, rather than being labeled as having schizophrenia. For this group, prescribed antipsychotics for an 18 month period was not associated with the risk of death.
Tenth Study
This 2015 study, titled “Antipsychotic Treatment and Mortality in Schizophrenia,” was published in Schizophrenia Bulletin. It looked at the same Sweden data set as our “Fourth Study” and “Eighth Study.” Each had looked at the follow-up that began on January 1, 2006 and ended on December 31, 2010.
The study did do some statistical analyses that I was not able to identify in the earlier similar studies. For example, it found that death due to respiratory disease was highest for those in the high-dose antipsychotic group, whereas those in the no exposure group had the lowest mortality due to respiratory disease.
Also, one of its statistical analyses indicated that no medication use was associated with elevated mortality only for patients who had been hospitalized within 1 year prior to start of follow-up (ie, during year 2005), but not for patients who had never received inpatient treatment. Patients who were hospitalized were probably placed on “antipsychotics” during their stay. Those who were not hospitalized were far less likely to have ever been placed on these types of drugs at any point. Thus, this statistical finding suggests that the group of patients who really had not been exposed to these types of drugs may have been no more likely to die during this 5 year period than those who had prescriptions for “antipsychotics” and picked them up, or had a family member that pick them up at a pharmacy.
High antipsychotic use was associated with higher mortality than medium use. Mortality risk increased more in women than in men with high antipsychotic exposure. Finally, Jari Tiihonen, who has a great many connections with the pharmaceutical industry and was involved in most of the other studies that suggest a possible reduction in mortality with the use of “antipsychotics,” was, once again, one of the authors of this study.
Conclusion
The available research is not so perfect that we can make any definite conclusions regarding whether or not “antipsychotics” either increase or decrease mortality. That said, when we look at all of the research studies on the list provided by my respectful critic, along with the research left off of his list, my impression, certainly fallible, is as follows: For people experiencing the challenging concerns that result in people getting labeled as having schizophrenia, it would be healthier, and lead to longer lives, if we took all of the cost of promoting, manufacturing, and prescribing these drugs, and use it instead to provide safe, clean, kind, supportive places for them to get help.
Last year I published a post titled “Are Antipsychotics Beneficial?” (see HERE).
Robert Whitaker
Although I had personally reviewed the research, I relied on my method of presenting this information to readers by summarizing a free PDF written by the highly regarded science writer, Robert Whitaker, titled, “The Case Against Antipsychotics: A Review of Their Long-term Effects.” By clicking on the blue title, you can read all of his arguments.
Whitaker’s most recent book, Anatomy of an Epidemic, provides an in-depth exploration of medical studies, and concludes that there are serious problems with the conventional wisdom of treating those labeled as mentally ill with drugs.
Toward the end of my post on antipsychotics, I provided the following quote from Whitaker’s free PDF:
“The drugs are supposed to provide the benefit of reducing psychotic symptoms. But the research reveals that, over the long term, this benefit turns into a negative, and so, over the long-term, there are only negatives to be chalked up: the increased chronicity of psychotic symptoms, the impaired functional outcomes, the worse cognitive functioning, and, of course, a broad range of “side effects,” such as tardive dyskinesia, metabolic problems, sexual dysfunction, and so forth. Such is the bottom-line arithmetic that makes the case against antipsychotics.”
In my post, I ended up supporting Whitaker’s conclusions. Consequently, some of my readers showered me with praise for having the courage to stand up to the powerful pharmaceutical-psychiatric institutions, while others showered me with the most disrespectful insults known to the human race. And then there were those who disagreed with me but did so in a respectful manner. I believe it is my responsibility to now provide them a respectful response.
Those disagreers who remained respectful put forth basically two types of arguments. The most common of these were from people who personally know a family member or friend who has been “diagnosed” as having schizophrenia and from their observations the “antipsychotic” drug treatment appears to be helpful. Others had seen some research that has convinced them that the drugs reduced the risk of death.
My post today will focus on the first of these arguments. I review the evidence regarding whether or not these drugs reduce the risk of death HERE.
The Apparent Helpfulness of Antipsychotic Treatment
Any pill prescribed by a doctor will lead many to experience a placebo effect, which can be, for a period of time, helpful. I hasten to point out that a person can get a placebo effect with non-drug treatment approaches as well, and this would avoid the various harms associated with this type of drug.
In addition to a placebo effect, the perception of helpfulness of a drug can come about when a patient in an agitated state first comes to the attention of a psychiatrist. These drugs are not only known as “antipsychotics,” but also “major tranquilizers,” because they sometimes do appear to calm someone in distress.
Unfortunately, once someone begins to take these drugs to help with agitation, when they try to come off of the drug, they are left with drug withdrawal experiences that have been described as awful. I hasten to point out that there are other ways to help someone to calm down that need not rely on these types of drugs. I have worked on many occasions with people who are agitated, and without the aid of a drug prescription I listened in a caring way, and in time the person eventually calmed down. If, however, you give someone a drug that calms the person down, it is sometimes much easier, and less time consuming. For people who witness someone they care about in high distress drift into a calmer state upon taking an “antipsychotic,” this can seem enormously helpful.
Moreover, for a period of several months, the person who had been experiencing some mental health concern might, after taking these types of drugs and being a bit calmer, may begin to function better in several ways, such as sleeping more soundly, or having friendlier relationships.
Some of them would have recovered in a fairly short period without the drug, but because they recovered while taking the drug, they, and their loved ones, attribute the improvement to the effectiveness of the drug. If the person tries to see whether the improvement was due to the drug or the natural recovery process, he or she may try to stop ingesting the drug. However, the withdrawal from the drug, as I mentioned above, often causes a nasty physiological reaction which, in some ways, is similar to someone who is a coffee drinker who suddenly decides to stop, cold turkey. However, the “antipsychotic” physiological withdrawal reaction can be experienced as much worse. When people who care about this person see the downward spiral that occurs from the physiological withdrawal reactions, they may come to attribute it to the person’s “mental illness” returning, and thus, the illusion of long term effectiveness is now deeply entrenched.
Another way in which the illusion of the long term effectiveness of the drugs can occur has to do with the fact that even when the “diagnosed” person is not functioning well on a drug treatment regimen, human beings can always imagine that the patient would be doing even worse without taking the drug. And of course, when the patient does try to go off the drug, the raging physiological withdrawal process occurs. So, in this way, the combination of the belief that the patient could be doing worse, and upon becoming worse when trying to do without the drug, it convinces people that the drug treatment is helpful.
Finally, oftentimes family members are the ones who had advocated that the distressed person go to a psychiatrist and comply with the drug treatment. Once they take that position, and tell others what they had done, information that comes their way in the form of the distressed person having bad side-effects, or hearing from people who take the position that the drugs may be more harmful than helpful, a psychological phenomenon known as cognitive dissonance occurs. The principle of cognitive dissonance states that human beings strive for internal psychological consistency. When they experience internal inconsistency they become psychologically uncomfortable and a major way that they try to reduce the discomfort is by avoiding circumstances and contradictory information likely to increase the magnitude of the cognitive dissonance.
So, in summary, the five ways that people may get the false impression that over the long term the drugs are effective are:
The placebo effect,
The initial calming effect of the drug,
Attributing observed improvement as being due to the drug rather than to the natural course of the experience,
Whenever the drug taker is not doing well, it is easy to imagine he or she would be doing even worse if he or she was not taking the drug,
Cognitive dissonance.
(By the way, upon reading this, if some of you who have been taking these types of drugs decide that you want to try to wean yourself off, a good resource to help can be accessed HERE.)
Maybe I’m the One Suffering From Cognitive Dissonance
I have publicly supported the argument that these drugs cause more harm than good. Therefore it can be argued, it is I who suffer from cognitive dissonance whenever evidence comes my way that might support the idea that these drugs are helpful in the long run.
This point is worth considering. What I have done to avoid falling into this trap is to thoroughly review the research regardless of whether or not it supports my position. Here’s a partial description of what I found.
By the late 1990s, investigators had reported that antipsychotics caused basal ganglion structures and the thalamus to swell, and the frontal lobes to shrink, with these changes in brain volumes “dose related.” Then, in 1998, Raquel Gur, from the University of Pennsylvania, reported that the swelling of the basal ganglia and thalamus was “associated with greater severity of symptoms.”
Soon Nancy Andreasen, who was then editor-in-chief of the American Journal of Psychiatry, reported on her findings from a study of 500 schizophrenia patients. In 2003, she reported that their frontal lobes shrank over time, and that this shrinkage was associated with a worsening of symptoms and functional impairment, and after five years, with a worsening of cognitive abilities.
While Andreasen initially attributed this shrinkage of the frontal lobes to what she referred to as the schizophrenia disease process, in 2011 she announced that long-term use of the old standard antipsychotics, the new antipsychotics, and clozapine were all “associated with smaller brain tissue volumes.” She found that this brain shrinkage was dose related; the more drug a person was given, the greater the association “with smaller grey matter volumes.” A loss in white matter volume was also “most evident among patients who received more antipsychotic treatment.” Illness severity and substance abuse had “minimal or no effects” on brain volumes, she concluded.
Numerous studies have now reported that antipsychotics induce changes in brain volumes, which, German investigators concluded in 2014, “exert adverse effects on neurocognition, symptoms and psychosocial functioning.”
The MRI studies provide objective evidence that antipsychotics cause changes in brain volumes that are associated with a worsening of symptoms, and a worsening of functional impairment.
So, with all due respect to my critics, I respectfully submit the above argument that the belief that antipsychotics are helpful in the long run is an illusion.
——————————-
Some people will enjoy reading this blog by beginning with the first post and then moving forward to the next more recent one; then to the next one; and so on. This permits readers to catch up on some ideas that were presented earlier and to move through all of the ideas in a systematic fashion to develop their emotional and social intelligence. To begin at the very first post you can click HERE.
As I write this, it is the time of year that for most Americans the fresh new school year is well on its way. It is also the time when we begin to see some teachers becoming frustrated with some of their new students because they won’t sit quietly during lessons, or their attention too frequently wanders. And so, parents start getting phone calls from these frustrated teachers, urging them to consider having their son or daughter evaluated for ADHD. “There are medications available for children that help these kinds of problems,” the teachers explain.
Meanwhile the pharmaceutical industry, with its enormous financial resources, has been skillfully promoting how helpful drugs like Ritalin are. Dramatically less funded are folks who try to present the negative consequences of this drug taking approach.
To do my best to offer balance to the pharmaceutical industry’s point of view, in earlier posts I review the research pertaining to how effective and ineffective these drugs are (see HERE, HERE and HERE), and conclude that for many kids there is a modest short-term improvement in the teacher’s goals, but they then develop tolerance to the drug, and thus the positive effects wear away. In the end, students are subjected to the negative side-effects, while not improving their achievement levels, social skills, or high school graduation rates. At best, thousands of dollars have been wasted. At worst, the side effects of the drugs might have led to some serious physically harmful consequences.
In another post (see HERE), I review safe alternatives to drug treatment. I also point out that many of the students viewed as having ADHD really have an attention priority difference (see HERE). That is, many of these children have no problem paying attention to many types of tasks, such as art projects, singing songs, and playing sports, but find academic school lessons boring. Others are the youngest student in the class and are actually acting in a manner typical for their age.
Now, sometimes I meet parents who tell me that they have decided to go along with their physician’s recommendation that their child be placed on Ritalin or some other similar stimulant drug. I certainly respect their right to make decisions concerning how to raise their child, and I certainly don’t throw any insult at them. Nevertheless, it does sadden me when I hear about this decision, for I become concerned about the child’s stomach, kidney, nerves, hormones, developing brain, and bone structure. Drugs that physicians have said are safe and effective have, in the past, proven to be far more toxic than anyone ever dreamed. The latest such case involves the use of pain killers that fall in the class of Oxycontin, which many physicians cooperated in creating a situation now declared a national emergency. I for one have been deeply grieving over the suffering of the tens of thousands of family members caught up in this horrible deadly mess.
I grieve as well over the social misery that goes along with being singled out as a child that must take a pill to fix the problem said to be in his or her brain. More than a few kids have told me that this process, for them, became a dreaded experience.
I believe that teaching our children to turn to drugs when they are dissatisfied with their behavior or mood runs counter to the values of a healthy lifestyle.
I prefer to put forth a view that encourages us to teach our kids about the value of keeping our bodies in lifelong possession of its full youthful state by avoiding the use of stimulants and narcotics. I wish to teach our kids it is possible that the morning sun and air are far better and healthier intoxicants. Doing something that puts a smile on the lips of a loved one, accomplishing a valued challenging task, providing assistance to another human being–these are the directions I wish we would point to when we guide a child toward a fulfilling life.